# FDA Inspection 1199304 - Reveragen Biopharma Inc. - March 06, 2023

Source: https://www.keypedia.com/records/fda_inspections/reveragen-biopharma-inc/7b9c6294-f474-42d7-8a48-9f7b86f9126d
Source feed: FDA_Inspections

> FDA Inspection 1199304 for Reveragen Biopharma Inc. on March 06, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1199304
- Company Name: Reveragen Biopharma Inc.
- Inspection Date: 2023-03-06
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/reveragen-biopharma-inc/eaf70eaf-05c9-4025-b737-094553dcf19f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c